GLP1-TZ  is a synthetic analog of gastric inhibitory polypeptide (GIP), possessing dual functionality by interacting with both GIP and glucagon-like peptide-1 (GLP-1) receptors. Laboratory research has extensively explored GLP1-TZ for its potential roles in glucose metabolism, insulin secretion, and appetite modulation. Studies indicate that GLP1-TZ may influence insulin release, enhance insulin sensitivity, and affect satiety signaling pathways.

Scientific investigations are also examining potential interactions of GLP1-TZ with cardiovascular health pathways and metabolic processes related to conditions such as non-alcoholic fatty liver disease (NAFLD). Further laboratory research is exploring its possible impacts on adipokine profiles, including modulation of adiponectin levels.

Purity: >99% (HPLC verified)

Formulation: Lyophilized powder for reconstitution

Molecular Formula: C225H348N48O68

Molecular Weight: 4813.524 g/mol

CAS Number: 2023788-19-2

PubChem CID: 156588324

Synonyms: Tirzepatide, P1206, LY3298176, BG 121, Dual GIP and GLP-1 receptor agonist (GIP/GLP-1RA)

Important Notice:This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.